创伤后应激障碍（PTSD）和药物依赖：奖励循环的神经影像*-猫眼课题宝

创伤后应激障碍（PTSD）和药物依赖：奖励循环的神经影像*

批准号：

7466339

负责人：

IGOR ELMAN

金额：

$9.49万

依托单位：

MCLEAN HOSPITAL

依托单位国家：

美国

项目类别：

财政年份：

2004

资助国家：

美国

项目状态：

已结题

起止时间：

2004-06-01 至 2009-05-31

来源：

https://reporter.nih.gov/project-details/7466339

关键词：

Address Alcohols Anxiety Appendix Area Brain Categories Child Chronic Chronic stress Clinical Research Clinical Trials Cocaine Cocaine Dependence Collection Color Consumption Data Development Development Plans Disease Dose Drug Addiction Drug usage Emotional Experimental Psychology Face Functional Magnetic Resonance Imaging Functional disorder Gambling Instruction Letters Literature Methods Mind Minority Monitor Morphine Nucleus Accumbens Numbers Pattern Pharmaceutical Preparations Phase Post-Traumatic Stress Disorders Process Progress Reports Psychopharmacology Publications Research Research Design Resources Rewards Safety Score Severities Signal Transduction Statistically Significant Stimulus Stress Substance Use Disorder Substance of Abuse System Therapeutic Intervention Vertebrates Visual Woman Women&apos s Group addiction avoidance behavior conditioned fear design human subject indexing insight male neuroimaging pre-clinical reinforcer response reward circuitry social visual process visual processing

项目摘要

项目成果

IGOR ELMAN的其他基金

相似基金

相关文献

中文摘要

翻译

四张).12 其他传记小品(每份不得超过四页--请参阅说明书)15个资源.........................................................................................................................42 研究计划修订申请简介(不超过3页)................................................................................................................ 补充申请简介(不超过一页)..................................................................................................... 48 A.特定目标............................................................................._。......................................................................................... 48 B.背景和意义...................................................……|。........................................................................................我 57 C，初步研究/进度报告/(项目A-D：不超过25页*)“_t 第一阶段进度报告(仅限SBIR/STTR第二阶段)F SBIR/STTR阶段L：项目A-D限制t？15页I [3.研究设计和方法................................................_..........................................................................................62 E.人类受试者..........................................................................................................................................................................73 保护人类受试者(如正面第4项标明“是”，则为必填项) 包括妇女(如果页面上的第4项标记为“是”，则为必填项)...................................................................... 包括少数族裔(如果页面上的项目4标记为“是”，则为必填项).................................................................... 包括儿童(如果主页上的第4项标记为“是”，则为必填项)...................................................................... 数据和安全监测计划(如果页面上的第4项标记为是且临床为I、II或III期，则需要填写建议进行试验....................................................................................................................... F.脊椎动物...................................................................................................................................................................... G.引用....................................................................................................................的文献........................................................82 H.联合体/合同安排................................................................................................................... I.支持函(例如，咨询公司)......................................................................................................................96 J.产品开发计划(仅限SBIRISTTRII阶段和快速通道)............................................................................... 核对表........................................................................................................................一百零二检查是否附录(五套整理。附录不需要页码。) 附录为包括在内附录除非特别要求，否则不允许第一阶段SBIR/S TTR使用T。接受出版的出版物和稿件数量(不超过10份) 其他项目(列表)：附录一初步研究中的数字色板小灵通398(05/01版)第3页表格第3页

英文摘要

four pa.qes) ..................... 12 Other Biographical Sketches (Not to exceed four pages for each - See instructions)) ............................ 15 Resources ........................................................................................................................................................ 42 Research Plan Introduction to Revised Application (Notto exceed 3 pages) ................................................................................................................ Introduction to Supplemental Application (Not to exceed one page) ..................................................................................................... 48 A. Specific Aims ............................................................................ ._. ......................................................................................... 48 B. Background and Significance ................................................... .....|. ........................................................................................ I 57 C, Preliminary Studies/Progress Report/ _ (Items A-D: not to exceed 25 pages*) "_t Phase I Progress Report (SBIR/STTR Phase II ONLY) F SBIR/STTR Phase l: ltems A-D limited t¿15 pages I [3. Research Design and Methods ................................................ _ .......................................................................................... 62 E. Human Subjects .......................................................................................................................................................................... 73 Protection of Human Subjects (Required if Item 4 on the Face Page is marked "Yes") Inclusion of Women (Required if Item 4 on the Face Page is marked "Yes") ...................................................................... Inclusion of Minorities (Required if Item 4 on the Face Page is marked "Yes") .................................................................... Inclusion of Children (Required if Item 4 on the Face Page is marked "Yes") ...................................................................... Data and Safety Monitoring Plan (Required if Item 4 on the Face Page is marked "Yes" anda Phase I, II, or III clinical trial is proposed ............................................................................................................................................................... F. Vertebrate Animals ...................................................................................................................................................................... G. Literature Cited ............................................................................................................................................................................ 82 H. Consortium/Contractual Arrangements ....................................................................................................................................... I. Letters of Support (e.g., Consultants) ......................................................................................................................................... 96 J. Product Development Plan (SBIRISTTR Phase II and Fast-Track ONLY) ............................................................................... Checklist ........................................................................................................................................................... 102 Check if Appendix (Five collated sets. No page numbering necessary for Appendix.) Appendix is Included Appendices NO T PERMITTED for Phase I SBIR/S TTR unless specifically solicited. Number of publications and manuscdpts accepted for publication (not to exceed 10) Other items (list): Appendix I Color Plates of Figures in Preliminary Studies PHS 398 (Rev. 05/01) Page 3 Form Page 3

期刊论文(10)

专著(0)

科研奖励(0)

会议论文